Akira Sawaki
Kamakura, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
TMPRSS2-ERG Fusion Identified by Comprehensive Genomic Profiling Reveals Prostatic Origin in Cancer of Unknown Primary: A Case Report.
Journal: Cureus
Published: April 04, 2026
Pimitespib for advanced gastrointestinal stromal tumor: a plain language summary of the CHAPTER-GIST-301 study.
Journal: Future oncology (London, England)
Published: July 11, 2025
English version of Japanese Clinical Practice Guidelines 2022 for gastrointestinal stromal tumor (GIST) issued by the Japan Society of Clinical Oncology.
Journal: International journal of clinical oncology
Published: December 27, 2023
Cutaneous Metastasis of Transverse Colon Cancer with an Aberrant Pattern of CK7/CK20/CDX2 and High Microsatellite Instability.
Journal: Internal medicine (Tokyo, Japan)
Published: May 10, 2023
Pimitespib in patients with advanced gastrointestinal stromal tumor (CHAPTER-GIST-301): a randomized, double-blind, placebo-controlled phase III trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 15, 2022
A rare case of pancreatic neuroendocrine neoplasm causing Cushing's syndrome.
Journal: Clinical journal of gastroenterology
Published: September 23, 2021
Early Changes in Alpha-Fetoprotein Are a Useful Predictor of Efficacy of Atezolizumab plus Bevacizumab Treatment in Patients with Advanced Hepatocellular Carcinoma.
Journal: Oncology
Published: August 16, 2021
Correlation between immune-related adverse events and prognosis in patients with various cancers treated with anti PD-1 antibody.
Journal: BMC cancer
Published: March 09, 2020
Efficacy and safety of TAS-116, an oral inhibitor of heat shock protein 90, in patients with metastatic or unresectable gastrointestinal stromal tumour refractory to imatinib, sunitinib and regorafenib: a phase II, single-arm trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 15, 2019
Correction to: Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor.
Journal: Investigational new drugs
Published: March 24, 2019
Efficacy and safety of sunitinib in Japanese patients with progressive, advanced/metastatic, well-differentiated, unresectable pancreatic neuroendocrine tumors: final analyses from a Phase II study.
Journal: Japanese journal of clinical oncology
Published: August 15, 2018
Last Updated: 09/26/2026